CDD3505

CAS No. 173865-33-3

CDD3505( 4-nitro-1-trityl-1H-imidazole )

Catalog No. M26553 CAS No. 173865-33-3

CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
5MG 30 In Stock
10MG 51 In Stock
25MG 90 In Stock
50MG 129 In Stock
100MG 193 In Stock
200MG 290 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CDD3505
  • Note
    Research use only, not for human use.
  • Brief Description
    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • Description
    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • In Vitro
    CDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
  • In Vivo
    ——
  • Synonyms
    4-nitro-1-trityl-1H-imidazole
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    Anti-infection| Bacterial| HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    173865-33-3
  • Formula Weight
    355.397
  • Molecular Formula
    C22H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 14.29 mg/mL (40.21 mM)
  • SMILES
    [O-][N+](=O)c1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chaudhuri S, et al. Binding of the bioflavonoid robinetin with model membranes and hemoglobin: Inhibition of lipid peroxidation and protein glycosylation. J Photochem Photobiol B. 2010 Jan 21;98(1):12-9.
molnova catalog
related products
  • Xylazine

    Xylazine is α2-adrenergic receptor agonist.

  • JNJ0966

    JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).

  • Enerisant HCl

    Enerisant HCl is a novel potent and selective histamine H3 receptor antagonist, a substrate for P-gp, mediated by cytochrome P450 (CYP) and transporter proteins.